Free Trial
NYSEAMERICAN:BDR

Blonder Tongue Laboratories (BDR) Stock Price, News & Analysis

Blonder Tongue Laboratories logo
$0.18 0.00 (0.00%)
As of 06/10/2026

About Blonder Tongue Laboratories Stock (NYSEAMERICAN:BDR)

Key Stats

Today's Range
$0.18
▼
$0.18
50-Day Range
$0.18
▼
$0.18
52-Week Range
$0.28
▼
$1.91
Volume
N/A
Average Volume
364,033 shs
Market Capitalization
$2.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Blonder Tongue Laboratories, Inc. is a communications equipment company that develops and supplies products for broadband, cable television and video distribution networks. Founded in 1950, the company has historically served cable operators, broadband service providers, system integrators and commercial, institutional and hospitality customers.

Its product portfolio has included headend and distribution equipment such as modulators, encoders, signal processors, amplifiers, fiber-optic transmission products and related broadband infrastructure. These products are designed to support the processing, transport and delivery of television programming, data and other video services across cable and private broadband networks.

Blonder Tongue has marketed its equipment to customers in the United States and international markets, with applications spanning cable television systems, private cable networks, hotels, hospitals, schools, government facilities and other organizations that operate centralized video or broadband systems.

AI Generated. May Contain Errors.

Receive BDR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Blonder Tongue Laboratories and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BDR Stock News Headlines

The case for $20,000 gold before year end
President Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and America's $40 trillion national debt to a potential surge in gold prices, with some forecasts pointing to $10,000 or even $20,000 gold. Dr. David Eifrig, a 40-year market veteran and former Goldman Sachs Vice President, says an unusual plan involving Trump and two other top officials could fuel the biggest gold bull run in decades. Eifrig has shared his top gold pick tied to this developing story.tc pixel
How the colour of your tongue reveals your health
Abbott Laboratories BDR (ABTT34)
Forest Laboratories
Blonder Tongue Laboratories, Inc. (BDRL)
See More Headlines

BDR Stock Analysis - Frequently Asked Questions

Blonder Tongue Laboratories' stock was trading at $0.1775 on June 12, 2026. Since then, BDR shares have increased by 0.0% and is now trading at $0.1775.

Blonder Tongue Laboratories, Inc. (NYSEAMERICAN:BDR) issued its earnings results on Friday, May, 15th. The technology company reported ($0.21) earnings per share for the quarter. The technology company had revenue of $4.05 million for the quarter. Blonder Tongue Laboratories had a negative net margin of 8.71% and a negative trailing twelve-month return on equity of 56.15%.

Shares of BDR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Blonder Tongue Laboratories investors own include VBI Vaccines (VBIV), Nokia (NOK), Agile Therapeutics (AGRX).

Company Calendar

Last Earnings
5/15/2020
Today
10/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Communications Equipment
Sub-Industry
Communications Equipment
Current Symbol
NYSEAMERICAN:BDR
CIK
1000683
Employees
85
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.47 million
Net Margins
-8.71%
Pretax Margin
-8.62%
Return on Equity
-56.15%
Return on Assets
-12.11%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
1.35
Quick Ratio
0.63

Sales & Book Value

Annual Sales
$16.38 million
Price / Sales
0.14
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.11 per share
Price / Book
1.61

Miscellaneous

Outstanding Shares
13,326,000
Free Float
5,337,000
Market Cap
$2.37 million
Optionable
Not Optionable
Beta
0.23
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NYSEAMERICAN:BDR) was last updated on 10/4/2026 by MarketBeat.com Staff.
From Our Partners